Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity

Kang TB, Park HI, Suh Y, Zhao YG, Tschesche H, Sang QXA (2002)
JOURNAL OF BIOLOGICAL CHEMISTRY 277(50): 48514-48522.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ;
Abstract
We investigated the regulation of the proteolytic activity of human adamalysin 19 (a disintegrin and metalloproteinase 19, hADAM19). It was processed at Glu(586) (P1)-Ser(587)(P1') site in the cysteine-rich domain as shown by protein N-terminal sequencing. This truncation was autolytic as illustrated by its R199A/R200A or E346A mutation that prevented the zymogen activation by furin or abolished the catalytic activity. Reagents that block furin-mediated activation of pro-hADAM19, decRVKR-CMK, A23187, and brefeldin A abrogated this processing. The sizes of the side chains of the P1 and P1' residues are critical for the processing of hADAM19. The amount of processing product in the E586Q or S587A mutant with a side chain almost the same size as that in the wild type was almost equal. Conversely, very little processing was observed when the size of the side chain was changed significantly, such as in the E586A, E586G, or S587F mutants. Two mutants with presumably subtle structural distinctions from wild type hADAM19, E586D and S587T, displayed rare or little processing and had very low capacities to cleave alpha2-macroglobulin and a peptide substrate. Therefore, this processing is necessary for hADAM19 to exert its proteolytic activities. Moreover, a new peptide substrate, Ac-RPLE-SNAV, which is identical to the processing site sequence, was cleaved at the E-S bond by soluble hADAM19 containing the catalytic and disintegrin domains. This enzyme cleaved the substrate with K-m, k(cat), and k(cat)/K-m of 2.0 mm, 2.4/min, and 1200 M-1 min(-1), respectively, using a fluorescamine assay. Preliminary studies showed that a protein kinase C activator, phorbol 12-myristate 13-acetate, promoted the cellular processing of hADAM19; however, three calmodulin antagonists, trifluoperazine, W7, and calmidazolium, impaired this cleavage, indicating complex signal pathways may be involved in the processing.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Kang TB, Park HI, Suh Y, Zhao YG, Tschesche H, Sang QXA. Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(50):48514-48522.
Kang, T. B., Park, H. I., Suh, Y., Zhao, Y. G., Tschesche, H., & Sang, Q. X. A. (2002). Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(50), 48514-48522.
Kang, T. B., Park, H. I., Suh, Y., Zhao, Y. G., Tschesche, H., and Sang, Q. X. A. (2002). Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY 277, 48514-48522.
Kang, T.B., et al., 2002. Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(50), p 48514-48522.
T.B. Kang, et al., “Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, 2002, pp. 48514-48522.
Kang, T.B., Park, H.I., Suh, Y., Zhao, Y.G., Tschesche, H., Sang, Q.X.A.: Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY. 277, 48514-48522 (2002).
Kang, TB, Park, HI, Suh, Y, Zhao, YG, Tschesche, Harald, and Sang, QXA. “Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity”. JOURNAL OF BIOLOGICAL CHEMISTRY 277.50 (2002): 48514-48522.
This data publication is cited in the following publications:
This publication cites the following data publications:

15 Citations in Europe PMC

Data provided by Europe PubMed Central.

Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.
Hoyne G, Rudnicka C, Sang QX, Roycik M, Howarth S, Leedman P, Schlaich M, Candy P, Matthews V., BMC Cancer 16(), 2016
PMID: 26912236
Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.
Masuyer G, Douglas RG, Sturrock ED, Acharya KR., Sci Rep 5(), 2015
PMID: 26403559
ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.
Suh J, Choi SH, Romano DM, Gannon MA, Lesinski AN, Kim DY, Tanzi RE., Neuron 80(2), 2013
PMID: 24055016
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases.
Franze E, Caruso R, Stolfi C, Sarra M, Cupi ML, Ascolani M, Sedda S, Antenucci C, Ruffa A, Caprioli F, MacDonald TT, Pallone F, Monteleone G., Inflamm. Bowel Dis. 19(3), 2013
PMID: 23429442
Identification of a thrombin cleavage site and a short form of ADAMTS-18.
Wang J, Zhang W, Yi Z, Wang S, Li Z., Biochem. Biophys. Res. Commun. 419(4), 2012
PMID: 22386991
ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2.
Tanabe C, Hotoda N, Sasagawa N, Futai E, Komano H, Ishiura S., Biochem. Biophys. Res. Commun. 396(4), 2010
PMID: 20460109
In silico analysis of neuregulin 1 evolution in vertebrates.
Chou CF, Ozaki M., Biosci. Rep. 30(4), 2010
PMID: 19681757
ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.
Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, Reiss K, Maes E, Snellinx A, Serneels L, Nyabi O, Annaert W, Saftig P, Hartmann D, De Strooper B., J. Biol. Chem. 284(17), 2009
PMID: 19213735
ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration.
Melenhorst WB, van den Heuvel MC, Timmer A, Huitema S, Bulthuis M, Timens W, van Goor H., Kidney Int. 70(7), 2006
PMID: 16900093
(Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T, Jorissen E, Reiss K, Hartmann D., Birth Defects Res. C Embryo Today 78(1), 2006
PMID: 16622847
ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons.
Goldsmith AP, Gossage SJ, ffrench-Constant C., J. Neurosci. Res. 78(5), 2004
PMID: 15505805
Isolation and embryonic expression of avian ADAM 12 and ADAM 19.
Lewis SL, Farlie PG, Newgreen DF., Gene Expr. Patterns 5(1), 2004
PMID: 15533821
ADAM proteins in the brain.
Novak U., J Clin Neurosci 11(3), 2004
PMID: 14975408

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 12393862
PubMed | Europe PMC

Search this title in

Google Scholar